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FSC1/AKAP82 (13) . Moreover, RIα was shown to be tightly sequestered (K D ~ 10nM) to AKAP CE (an AKAP identified from C. elegans) in vitro and in the intact cell (14) .
Recent studies have elucidated several criteria for the selectivity of AKAPs between PKA isoforms (RI vs. RII) (15) (16) (17) .
Scanning mutagenesis o f the RIα-specific domain of FSC1/AKAP82 and the RII-specific domain of Ht31 showed that single amino acid residues in these domains determine RI and RII binding specificity (15) . Also, point mutations introduced into the RIα/RIIα dual specificity domain of FSC1/AKAP82 converted it into an RI or RII preferential binding domain, suggesting that the size of the aliphatic side chain at consensus positions within the amphipathic α−helix determines RI/RII selectivity (15) . Furthermore, the RII-tethering sequence of AKAP CE contains 3 large aliphatic amino acids (Leu 236 , Ile 248 , Leu 252 )
that generate an apolar surface for RI dimer binding (16) . This motif was determined to be essential for selective binding of R CE and exclusion of RII isoforms.
Although distinctive features of RI and RII tethering domains are being revealed, little is known about determinants of the selectivity of RII or RI for different AKAPs. It is estimated that any cell contains ~5-10 distinct AKAPs to adapt PKA for specialized functions (18) . In the heart, for example, at least two AKAPs have been identified, AKAP15/18 and AKAP100/mAKAP (or mAKAP, for muscle-specific AKAP). AKAP15 (independently identified as AKAP18) is a low molecular weight AKAP that associates with the plasma membrane via NH 2 terminal lipid modifications (19, 20) , and has been shown to modulate L-type Ca 2+ channel activity (19, 21) . MAKAP (previously called AKAP100) was originally identified in embryonic cardiac H9c2 cells (22) . mAKAP has been localized to the t -tubule/junctional SR in rat cardiomyocytes and cryostat sections of rat papillary muscle (23) , and is found concentrated at the nuclear membrane in frozen sections of rat cardiac ventricle (24) . Since PKA 5 regulates a broad range of cellular responses in the cardiac myocyte, AKAP-dependent PKA compartmentalization is an important mechanism for controlling the specificity o f substrate phosphorylation.
However, there is a serious lack of information on factors that underlie the ability of PKA to interact specifically with different anchoring proteins, in any cell type. We previously demonstrated that autophosphorylation of R II is one mechanism involved in regulating binding to Ht31 (the prototypical human thyroid AKAP) (25) . Therefore, the aims of this study were to determine whether cardiac isoforms of PKA regulatory subunits (RIα and RIIα) have preferential binding characteristics for distinct AKAPs expressed in the heart, and to examine the role of β-adrenergic stimulation in regulating PKA anchoring and distribution in the intact cell.
In addition, we aimed to demonstrate a role for AKAP targeting in regulating substrate phosphorylation in vivo. (5) . Blots were prepared as previously described (25) , then probed with excess AKAP peptides (100µM). Fluorescence corresponding to RII-bound peptide was quantified by StormImager TM analysis using a streptavidin-alkaline phosphatase conjugate as previously described (25) .
Experimental Procedures

AKAP peptides and overlay assay
Preparation of RI and RII
Purified recombinant RIIα was prepared as described (25) . Briefly, the RIIα recombinant plasmid (RII-pET11d), a gift of Dr. John D. Scott (Vollum Institute, Portland, OR), was used to transform E. coli bacteria strain BL21(DE3). RII recombinant protein was expressed under 2 mM IPTG induction followed by cAMP-agarose affinity purification (26), and characterized as described (25) . Vectors for the expression of the GFP-tagged proteins RII-EYFP, Ht31-ECFP and Ht31P-ECFP were constructed as previously described (27). CHO cells were stably transfected with Ht31-ECFP or HT31P-ECFP and then transiently transfected with RII-EYFP as described (27), and expression of Ht31-ECFP, HT31P-ECFP and RII-EYFP was confirmed by immunoblot analysis. The cDNA for RIα was a gift of Dr. Susan Taylor (UCSD, LaJolla, CA). The cDNA encoding RI was excised using NheI and MluI, then ligated into pIRES (Clontech). CHO cells were transiently transfected with RI-pIRES using lipofectamine PLUS (Life Technologies, Inc.) according to the manufacturer's protocol. Cells were harvested 48h post transfection using trypsin-EDTA, washed with PBS, and resuspended in HBS buffer (10mM HEPES, pH 7.4, 150 mM NaCl, 3 mM EDTA, 0.005% Surfactant P20). Expression of RI was confirmed by immunoblot analysis.
Adenovirus construction
Recombinant adenovirus directing the expression of either HA-tagged Ht31 peptide or HA-tagged Ht31P peptide was generated using standard procedures (28 at a density of 1 ×10 5 cells/ml, as previously described (25) . The viability of the isolated ventricular myocytes prepared in this manner was typically greater than 90%, as determined by rod-shaped morphology and lack of granulation or blebs. Adenovirus was diluted in serum free DMEM plus 0.5X penicillin/streptomycin to 1 x 10 7 plaque-forming units (pfu)/mL for a multiplicity of infection (MOI) of 100. Myocytes were infected for 1 h, then cultured for 48 h in viral-free medium.
PKA-dependent phosphorylation
Proteins were backphosphorylated by the c atalytic subunit of PKA (PKA cat ) and [ γ- 
Immunoblot analysis
Whole-cell lysates and myofibrillar fractions were prepared from rat v entricular cardiac myocytes as described (25, 30) . Proteins were backphosphorylated, denatured for 5 min at 95°C, in 50 mM Tris-HCl, pH 6.8, 1% SDS, 1.5% DTT, 5% glycerol, 0.05% bromophenol blue, then separated by 6% SDS-PAGE at 125 V, 90 mA for 1 h. Proteins were then transferred to nitrocellulose membranes at 100 V, 370 mA, for 1 h 45 min. The membranes were blocked in 3% fish gelatin (w/v) in Tris-buffered saline containing 0.1% Tween-20 (TBST). After two 10 minute washes in TBST, the membranes were incubated overnight with anti-Ti II mAb Ti104
(1:1000 dilution). This antibody was made against the immunoglobulin domain of titin and cross-reacts with the MBP-C, which contains a homologous immunoglobulin domain (31) (antibody kindly provided by Dr. J.P. Jin, Case Western Reserve University, Cleveland, OH).
An alkaline phosphatase-linked anti-mouse IgG was the secondary antibody, and the membranes were developed using Vistra™ ECF substrate. Fluorescence corresponding to the bands was quantified by StormImager TM analysis. Radiolabelled proteins on the same membrane were then exposed to storage phosphor screens and detected by StormImager TM analysis (phosphor mode).
Surface Plasmon Resonance (SPR) Spectroscopy
SPR was measured by a BIAcore 1000 instrument using streptavidin (SA) sensor chips 
where k a is the association rate, k d is the dissociation rate, C is the concentration of the injected analyte, and R is the response. Plots of dR/dt versus Rt have a slope of k s . When k s is plotted against C, the resulting slope is equal to k a . The dissociation rate, k d , was calculated by integrating the rate equation when C = 0, yielding ln(Rt 1 /Rt n ) = k d (t n -t 1 ). The equilibrium binding constants were calculated from the equation
Results
Specificity of AKAP interaction and characterization of RII-binding domains
The Ht31 peptide is widely used to mimic AKAP-RII interactions (6) or to inhibit them in intact cells (22, 32) . Ht31 forms an amphipathic helix that binds RII with nanomolar affinity and competes with full-length AKAPs for RII binding (25, 33) . The putative RII-binding region of AKAP15/18 (residues 29-42) was shown to be sufficient for RII binding, since corresponding peptides effectively blocked all RII binding when used as antagonist in RII-overlay assays (19) .
In addition, recent evidence suggests that the putative RII-binding domain of mAKAP (residues 2055-2072) can bind RII in overlays and function to anchor PKA holoenzyme inside cells, as determined by immunoprecipitation with anti-mAKAP antibody and assessment of kinase activity (24) . The RII-binding region of the full-length mAKAP is identical to the previously cloned AKAP100 (residues 392-408). The RII-binding domain sequences of these anchoring proteins are given in Figure 1 . The amphipathic α-helical region of AKAP15/18, mAKAP, and
Ht31 each differed in the size of the hydrophobic portion of the helix (Table 1) . Furthermore, within this region, each AKAP contained a distinctive number of hydrophobic residues with long aliphatic side chains (Leu, Ile, or Val).
To confirm the specificity of AKAP-RII interactions, we first used a solid-phase overlay assay with AKAP15/18 and mAKAP peptides. (6, 25) . RII or autophosphorylated RII (RII-P) was transferred to nitrocellulose, and the amount of bound AKAP15/18 or mAKAP peptide was determined by densitometric scanning, as described. Both peptides recognized RII-P and RII specifically at ~57 and ~55 kDa, respectively ( Figure 2A ). Furthermore, autophosphorylation of RII increased binding of AKAP15/18 and mAKAP both by ~140 % (Figure 2B ), consistent with our previous results for Ht31 (25) . Although semi-quantitative, this assay has limited sensitivity for measuring binding events; further determination of rate and affinity constants for AKAP:RII and AKAP:RII-P interactions was performed by surface plasmon resonance (SPR) spectroscopy.
Affinity of PKA-I and PKA-II for different anchoring proteins
SPR analysis allowed us to measure real-time binding kinetics of RIα and RIIα interactions with various AKAPs in solution. In the first series of experiments, samples of recombinant cardiac RIIα at the same concentration (120 nM) were injected over three different chip surfaces, each containing an equivalent amount of Ht31, mAKAP, or AKAP15/18 peptide.
Non-specific binding to the Ht31P control surface was subtracted from each trace. Figure 3 illustrates the differential binding of RIIα to these different AKAPs, in terms of amount bound (RU) after similar injections. Table 2 ). The K D for RIα-Ht31 interaction was 1.0 µM ( Table 2 ). There was no measurable binding of RIα to mAKAP or AKAP15/18.
These data are in agreement with previously reported K D values for RI-Ht31 and RII-Ht31 interaction by us and others using SPR (7, 10, 25 Figure 5A-C) . There was no difference between RII and RII-P binding (association or dissociation rates) to the Ht31P control surface, although RII-P samples consistently showed a positive bulk-shift effect which was most likely due to the presence of a high-refractive index component in the PKA cat buffer ( Figure 5D ).
Similarly, autophosphorylation of RIIα in living CHO cells enhanced AKAP binding.
CHO cells expressing RIIα fusion proteins were stimulated with forskolin plus 8Br-cAMP to activate the cAMP/PKA pathway. These conditions resulted in a significant (77%) increase in RIIα autophosphorylation. Binding of RIIα in CHO cell lysates to Ht31, mAKAP, and AKAP15/18 peptide surfaces was then measured by SPR. We previously demonstrated that RII-GFP fusion proteins behave in kinetically similar manner to purified RII in this system (27).
RIIα autophosphorylation resulted in a ~1-fold (no change), ~7-fold and ~82-fold increase in binding to Ht31, mAKAP and AKAP15/18, respectively ( Figure 6 ). The greater effect of RII autophosphorylation that we observed in vitro using excess PKA cat and recombinant RII, relative to the increase that we observed in stimulated CHO cells, most likely reflects a significant extent of basal RII phosphorylation in vivo (25) .
In vivo regulation of β-adrenergic signaling and substrate phosphorylation by AKAP anchoring
To further examine the requirement for AKAP targeting of PKA in regulating substrate phosphorylation in the intact cell, we used adenoviral-mediated gene transfer of Ht31 (a blocking peptide that disrupts AKAP-PKA interactions) and Ht31P (a negative control) to express these peptides in adult rat cardiomyocytes. We then assessed the effect of disruption of PKA targeting by endogenous AKAPs on substrate phosphorylation. Expression of Ht31-HA and Ht31P-HA peptides was confirmed by immunoblot analysis using an anti-HA antibody (not shown). Ht31-or Ht31P-expressing myocytes were then either stimulated with 10 nM isoproterenol (5 min), or unstimulated (vehicle control). Phosphorylation of endogenous PKA-substrates was subsequently measured by backphosphorylation.
β-adrenergic stimulation increased the phosphorylation of a ~145 kDa protein by 2.7-fold in the control, Ht31P-expressing, cells. However, in the Ht31-expressing myocytes, the increase in phosphorylation of this PKA-substrate upon β-stimulation was significantly decreased by 45%
(results represent the average of three determinations for 3 separate animals, Figure 7 ). This protein was present in the myofibrillar fraction but not present in sarcoplasmic reticulum (SR) vesicles purified from isolated cardiac myocytes. This protein was further identified as myosinbinding protein C (MBP-C) by immunoblot analysis (Figure 8 ). These results suggest that AKAPs are involved in regulating endogenous PKA substrate phosphorylation in vivo, and provide physiological evidence that disruption of AKAP targeting of PKA can attenuate β-adrenergic responsiveness in the heart.
Discussion
In this study, we demonstrate for the first time that different AKAPs in the heart bind RII with unique affinities, and are not selective for RI. We also show that phosphorylation of RII, either by stimulation of the cAMP/PKA pathway in the intact cell, or by direct RII autophosphorylation with PKA catalytic subunit, enhances AKAP binding. Furthermore, the magnitude of this effect is dependent on the specific AKAP and the sequence of its RII-binding domain.
We also provide novel evidence that AKAP targeting of PKA regulates the phosphorylation of endogenous PKA substrates in the adult rat heart. (35)).
In the heart, several proteins that act in concert to enhance cardiac contractility are phosphorylated by PKA during inotropic stimulation. The major PKA substrates in the cardiac myocyte are troponin I (36) and MBP-C (also named C-protein) (37) ], with a concomitant increase in crossbridge activation. PKA localization to these targets has been shown to involve association with certain anchoring proteins. For example, recent studies have specified the likely intracellular targeting l ocations of mAKAP and AKAP18 in the heart. AKAP15/18 has been shown to associate with the plasma membrane and modulate cardiac L-type Ca 2+ channel activity when coexpressed in HEK293 cells (19, 21) . mAKAP colocalized with RIIα in the region of the transverse-tubule/ junctional SR in rat cardiac myocytes (23) , and mAKAP also coimmunoprecipitated with RyR 2 (41).
We demonstrate, for the first time, that disruption of AKAP-mediated targeting of PKA alters substrate phosphorylation in adult cardiac myocytes. Specifically, we show that in Ht31-versus Ht31P-expressing myocytes, phosphorylation of MBP-C is significantly decreased (by ~45%) in response to treatment with 10 nM isoproterenol. This suggests that there may be at least one unidentified AKAP present in the cardiac myocyte that is localized to the myofibrillar apparatus. We are currently working to identify other endogenous proteins in the heart whose phosphorylation state may be regulated by AKAP targeting of PKA.
Under baseline conditions, we would predict that RII (and consequently PKA holoenzyme) binds preferentially to the higher affinity AKAPs, allowing for a localized response from this broad specificity kinase. However, based on our results we would expect that under stimulated conditions the affinity of RII is normalized among the multiple AKAPs present within the cell (i.e., PKA autophosphorylation has a de-localizing effect). This implies a redistribution of PKA holoenzyme toward certain subcellular locations and away from others, during β-adrenergic stimulation. Current efforts are underway in our lab to track the movement and redistribution of PKA and AKAPs in the cell by using fluorescence resonance energy transfer of GFP-fusion proteins. Together, differential AKAP affinity and RII autophosphorylation may be a mechanism for the selective activation of compartmentalized pools of PKA during β-
The results presented in this study suggest that there are important pathophysiological considerations as well. The PKA s ignaling pathway appears to be downregulated at several levels, beyond the β-receptor, in human heart failure. Protein phosphorylation mediated by β-adrenergic activation is decreased in the failing human heart (30, 42, 43) . We have previously shown decreased RII protein levels (30) and decreased RIIα autophosphorylation in human dilated cardiomyopathy (25) . Based on the results reported in this study, PKA binding to as α-helices with 3.6 amino acid residues/turn. 
